L-2-Oxothiazolidine-4-carboxylic acid reverses endothelial dysfunction in patients with coronary artery disease.
about
L-2-Oxothiazolidine-4-carboxylic acid or α-lipoic acid attenuates airway remodeling: involvement of nuclear factor-κB (NF-κB), nuclear factor erythroid 2p45-related factor-2 (Nrf2), and hypoxia-inducible factor (HIF)Arginine Thiazolidine Carboxylate Stimulates Insulin Secretion through Production of Ca2+-Mobilizing Second Messengers NAADP and cADPR in Pancreatic IsletsGlutathione attenuates coronary constriction to acetylcholine in patients with coronary spastic angina.Effect of ascorbic acid treatment on conduit vessel endothelial dysfunction in patients with hypertension.The role of oxidative stress in atherosclerosis: the hope and the hypeThe effect of L-arginine and creatine on vascular function and homocysteine metabolism.Simvastatin combined with antioxidant attenuates the cerebral vascular endothelial inflammatory response in a rat traumatic brain injury.Essential hypertension and oxidative stress: New insightsFlow-mediated dilatation.Vitamin C as an antioxidant: evaluation of its role in disease prevention.Free radicals, diabetes and endothelial dysfunction.Decreased aortic glutathione levels may contribute to impaired nitric oxide-induced relaxation in hypercholesterolaemia.Transport via SLC5A8 (SMCT1) is obligatory for 2-oxothiazolidine-4-carboxylate to enhance glutathione production in retinal pigment epithelial cellsAttenuation of ischemia-reperfusion injury by ascorbic acid in the canine renal transplantation.Endothelial dysfunction and diabetes: effects on angiogenesis, vascular remodeling, and wound healing.S-glutathionylation uncouples eNOS and regulates its cellular and vascular function.Steam-cooking rapidly destroys and reverses onion-induced antiplatelet activity.Oxidative stress in prehypertension: rationale for antioxidant clinical trials.The brachial artery remodels to maintain local shear stress despite the presence of cardiovascular risk factors.Postprandial hyperglycemia as an etiological factor in vascular failureL-2-oxothiazolidine-4-carboxylic acid attenuates oxidative stress and inflammation in retinal pigment epitheliumVitamin C: the known and the unknown and Goldilocks.Antioxidant therapy for management of oxidative stress induced hypertension.Antidiabetic effect of a prodrug of cysteine, L-2-oxothiazolidine-4-carboxylic acid, through CD38 dimerization and internalization.Contrasting effects of thiol-modulating agents on endothelial NO bioactivity.Endothelium-dependent vasorelaxation in inhibited by in vivo depletion of vascular thiol levels: role of endothelial nitric oxide synthase.In vivo monitoring of hepatic glutathione in anesthetized rats by 13C NMR.Novel role for low molecular weight plasma thiols in nitric oxide-mediated control of platelet function.Ebselen does not improve oxidative stress and vascular function in patients with diabetes: a randomized, crossover trial.L-2-Oxothiazolidine-4-carboxylate reverses glutathione oxidation and delays fatigue of skeletal muscle in vitro.Analysis of 2-oxothiazolidine-4-carboxylic acid by hydrophilic interaction liquid chromatography: application for ocular delivery using chitosan nanoparticles.Non-invasive assessment of brachial artery endothelial vasomotor function: the effect of cuff position on level of discomfort and vasomotor responses
P2860
Q28387954-3A0429C3-5B04-4C4A-9502-0EEF7F876E61Q28547080-7A70F318-9C5E-42F5-91CC-81702AA487A7Q31722720-6892A911-EDB8-4DB4-883A-C05F2826DA85Q31833621-AA0A1708-8F57-48B5-AE58-B71BA7E8D55AQ33645001-B92FB26B-12CC-4047-A9DC-60417129D836Q33734265-447C3B69-B0AC-468B-964C-4E8B4E01CA3DQ33809964-247C84DA-1F11-43F2-807B-CF539DF167A5Q33812887-6DF3234C-8581-49DF-BE2A-BC3339167C9EQ34078578-3833385C-3171-4DE7-B2A2-5C46A8FA35CAQ34175262-A7F7FD5D-EE5A-4B0C-A4CD-7C47306876A3Q34722600-8679D07C-BE9B-48F7-A07A-6FB4E0D53098Q35041980-2A13AAF5-02EF-4B72-AADA-8DC42556A48EQ35221438-0A2BB819-F0D3-48FF-91EE-FEE453539A07Q35622465-66A492A6-75C7-40F8-BB96-24695F5563B6Q35947546-51A8F034-B1BD-4098-8C11-D965648168C6Q36017535-0D4DE1E4-050D-4BC0-A234-1E8E7EDCFF5CQ36376883-F963F0B7-B13F-427D-A221-D714AEA6B15FQ37270961-9CAF9787-AF53-42F8-9616-F5A9A6202675Q37284858-8D1404E9-F055-484A-8131-EF663320EEBCQ37464262-272D7574-D126-4757-B62B-F7C718197C77Q37465024-0F79C287-BB35-4D97-8B17-00587588FBBBQ38710779-DC7CE33B-2600-4F44-B42B-1BE6DBEBC86CQ39252696-128AE0C6-8E83-446F-AD70-51D2AEAC9E1FQ40772226-9B44FEA2-C34A-4669-AD00-D15A2EF90BF9Q43666388-9C956AAC-38AF-4E8B-AE1A-A000194606C5Q43791156-B1FBC0B9-3C3C-4905-988E-24B43513EF95Q44125075-3143418E-4D38-443D-9C1C-FD71621698ECQ44151463-E063DE6E-AB23-4BED-AF9C-D22B6BB0F668Q45343619-EC3B56CF-096A-490D-8567-356B19C65EF9Q46029696-F8BDC41D-36E1-42BD-A3B3-762A8B16DFBCQ53318194-306E9CF8-095B-41DC-AAE9-86A172481980Q57073321-679DC7E0-8151-467F-A04F-07DE7F20A951
P2860
L-2-Oxothiazolidine-4-carboxylic acid reverses endothelial dysfunction in patients with coronary artery disease.
description
article científic
@ca
article scientifique
@fr
articolo scientifico
@it
artigo científico
@pt
bilimsel makale
@tr
scientific article published on March 1998
@en
vedecký článok
@sk
vetenskaplig artikel
@sv
videnskabelig artikel
@da
vědecký článek
@cs
name
L-2-Oxothiazolidine-4-carboxyl ...... with coronary artery disease.
@en
L-2-Oxothiazolidine-4-carboxyl ...... with coronary artery disease.
@nl
type
label
L-2-Oxothiazolidine-4-carboxyl ...... with coronary artery disease.
@en
L-2-Oxothiazolidine-4-carboxyl ...... with coronary artery disease.
@nl
prefLabel
L-2-Oxothiazolidine-4-carboxyl ...... with coronary artery disease.
@en
L-2-Oxothiazolidine-4-carboxyl ...... with coronary artery disease.
@nl
P2093
P2860
P356
P1476
L-2-Oxothiazolidine-4-carboxyl ...... s with coronary artery disease
@en
P2093
P2860
P304
P356
10.1172/JCI1155
P407
P577
1998-03-01T00:00:00Z